TB-500: Discovery & Research History
TB-500 (Thymosin Beta-4 Fragment) — how it was originally discovered, and what it has been studied for since.
How TB-500 Was Discovered
TB-500 is a synthetic fragment of a much older discovery: thymosin beta-4, a 43-amino-acid peptide first isolated from bovine thymus tissue in 1981 by Teresa Low and Allan Goldstein as part of NIH-funded research, with the complete amino acid sequence published by Low, Hu, and Goldstein that same year. At the time, thymosin beta-4 was studied primarily as an immunological molecule, in keeping with the thymus's role in immune function.
That understanding changed roughly a decade later. In the early 1990s, work by Safer, Bhaskara, Sanders, Goldstein, and Wang identified thymosin beta-4 as a major G-actin-sequestering molecule — meaning it binds and regulates the building blocks of the cell's actin cytoskeleton. That finding reframed the entire molecule, shifting it from an immune signal to a cytoskeletal regulator relevant to cell movement and tissue repair. TB-500 itself is a shorter, synthetic peptide developed later to reproduce that actin-binding activity in a smaller, more research-tractable molecule. The research that followed moved in clear stages: actin-mechanism work through the early 1990s, wound-healing animal models through the late 1990s, cardiac and neural model research through the 2000s, corneal research in the 2010s, and continued aging-biology and fragment-characterization research into the 2020s.
What TB-500 Has Been Studied For
TB-500's research applications follow directly from thymosin beta-4's actin-regulating mechanism, and it remains one of the most frequently referenced peptides in tissue-repair research literature.
- Tissue repair and regeneration research
- Cell migration studies
- Actin-binding mechanism research
TB-500 discovery & history questions
Does TB-500's research history mean it's approved for a particular use?
No. This page describes how TB-500 was originally discovered and what it has been studied for since — it is historical and educational context, not a claim about current regulatory approval, safety, or legal status anywhere. KYIN Peptides sells TB-500 strictly for laboratory research use.
What has TB-500 been studied for in research?
TB-500 is most commonly studied in tissue repair and regeneration research, cell migration studies, and actin-binding mechanism research.
Looking for TB-500 specs and pricing?
View purity, available sizes, and pricing on the product page.